Benefits of Tirzepatide for Weight Loss Based on clinical trials, patients using Tirzepatide may experience: Substantial A1C reductions Increased weight loss Improvements in cardiometabolic measures Improved triglycerides levels Reduced appetite Decreased blood pressure Improved insulin sensitivity Conclusion Tirzepatide had an overall safety and tolerability profile, similar to other therapies approved for the treatment of obesity
The right treatment depends on the individual patient
Of 133 patients, 27.8% more than one in four had a fasting glucose flagged above the reference range , often before HbA1c moves
This can predispose to achalasia-like symptoms and worsening of GERD [18, 19]
A limitation of our research was the inability to assess the effects of switching from dulaglutide to other GLP-1 receptor agonists, as they were unavailable except in fixed-ratio combinations such as insulin degludec/liraglutide and insulin glargine/ lixisenatide
Lilly's head of cardiometabolic health, Kenneth Custer, said that many people with T2D struggle to achieve improved glucose control and weight loss
